Skip to content

Measurement of vanilloïd Compounds in Urin of Autistic vs Control Patients, as Potential Biomarkers

Diagnostic of Autism by Measurement of vanilloïd Compounds in Urin

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04651972
Acronym
DIADAUVEDA
Enrollment
140
Registered
2020-12-03
Start date
2020-12-15
Completion date
2022-07-30
Last updated
2020-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Brief summary

In a former study, four vanilloid compounds were observed increased in the urin of autistic patients. The present study is aimed at performing a ambispective study to confirm or not these preliminary results. 70 urins from autistic children (already collected) will be compared to 70 urins of non autistic children (collected without intervention, remaining sample from the standard care), in terms of measurements of four vanilloid compounds using a GCMS apparatus.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
MALE
Age
2 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

: For cases : * Male children aged 2 years to less than 15 years inclusive years at time of sample collection * Children with a diagnosis of autism (ICD-10 F84.0) after assessment by a child psychiatrist. For healthy chlidren: * Children aged 2 years to less than 15 years old performing an ECBU at the CHRU of Nancy as part of their care. * Patient whose ECBU is negative with respect to cytobacteriology (absence of urinary infection). * Child can be matched to a CAS

Exclusion criteria

For cases: * Children in whom one of the following pathologies is found during the anamnesis or in the clinical record : (i) renal insufficiency; (ii) urinary tract infection at the time of sampling and/or metabolic disease * Children on antibiotic treatment at the time of collection For healthy chlidren : * children whose urine culture come from one of the following departments: Pediatric Nephrology (potential risk of renal failure) or Pediatric Neurology (potential risk of neurological disorder). * with a diagnosis of autism * with a metabolic disease * children undergoing antibiotic treatment at the time of collectio

Design outcomes

Primary

MeasureTime frameDescription
measurements of vanilloid compound in urinsthrough study completion, an average of 18 monthsThe primary end point is to determine if isolated or combinations of vanilloid compound measured in urin, may discriminate autistic vs non autistic childen

Contacts

Primary ContactMarc Merten, PhD
m.merten@chru-nancy.fr33 616 364 916
Backup ContactJean-Luc Olivier, MD, PhD, Pr
jl.olivier@chru-nancy.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026